...
rdy-img

Dr. Reddy’s Laboratories Ltd ADR, Common Stock

RDY

NYQ

$15.49

+$0.12

(0.78%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$13.11B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
19.7051
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.03M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.62%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.33
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$12.63 L
$16.89 H
$15.49

About Dr. Reddy’s Laboratories Ltd ADR, Common Stock

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameRDYSectorS&P500
1-Week Return5.45%-0.94%-2.6%
1-Month Return8.17%-5.08%-1.08%
3-Month Return-2.41%-10.62%3.45%
6-Month Return7.44%-6.18%8.57%
1-Year Return15.12%1.98%24.3%
3-Year Return23.35%-0.93%25.58%
5-Year Return89.87%33.84%84.07%
10-Year Return55.9%102.52%185.12%

Financials

Mar '20Mar '21Mar '22Mar '23Mar '245YR TREND
Total Revenue174.60B189.72B214.39B245.88B279.16B[{"date":"2020-03-31","value":62.54,"profit":true},{"date":"2021-03-31","value":67.96,"profit":true},{"date":"2022-03-31","value":76.8,"profit":true},{"date":"2023-03-31","value":88.08,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Cost of Revenue80.59B86.64B100.55B42.91B115.56B[{"date":"2020-03-31","value":69.74,"profit":true},{"date":"2021-03-31","value":74.98,"profit":true},{"date":"2022-03-31","value":87.01,"profit":true},{"date":"2023-03-31","value":37.13,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Gross Profit94.01B103.08B113.84B202.97B163.61B[{"date":"2020-03-31","value":46.32,"profit":true},{"date":"2021-03-31","value":50.78,"profit":true},{"date":"2022-03-31","value":56.09,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":80.61,"profit":true}]
Gross Margin53.84%54.33%53.10%82.55%58.61%[{"date":"2020-03-31","value":65.22,"profit":true},{"date":"2021-03-31","value":65.82,"profit":true},{"date":"2022-03-31","value":64.32,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":71,"profit":true}]
Operating Expenses61.25B70.12B76.80B117.61B95.88B[{"date":"2020-03-31","value":52.08,"profit":true},{"date":"2021-03-31","value":59.62,"profit":true},{"date":"2022-03-31","value":65.3,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":81.52,"profit":true}]
Operating Income37.05B36.06B40.82B96.28B67.73B[{"date":"2020-03-31","value":38.49,"profit":true},{"date":"2021-03-31","value":37.45,"profit":true},{"date":"2022-03-31","value":42.39,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":70.34,"profit":true}]
Total Non-Operating Income/Expense(19.11B)5.70B4.94B1.91B4.71B[{"date":"2020-03-31","value":-335.49,"profit":false},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":86.73,"profit":true},{"date":"2023-03-31","value":33.58,"profit":true},{"date":"2024-03-31","value":82.64,"profit":true}]
Pre-Tax Income18.03B28.32B32.30B60.48B71.87B[{"date":"2020-03-31","value":25.09,"profit":true},{"date":"2021-03-31","value":39.41,"profit":true},{"date":"2022-03-31","value":44.94,"profit":true},{"date":"2023-03-31","value":84.16,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income Taxes(1.47B)9.18B8.73B15.41B16.19B[{"date":"2020-03-31","value":-9.06,"profit":false},{"date":"2021-03-31","value":56.68,"profit":true},{"date":"2022-03-31","value":53.94,"profit":true},{"date":"2023-03-31","value":95.22,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income After Taxes19.50B19.15B23.57B45.07B55.68B[{"date":"2020-03-31","value":35.02,"profit":true},{"date":"2021-03-31","value":34.39,"profit":true},{"date":"2022-03-31","value":42.32,"profit":true},{"date":"2023-03-31","value":80.94,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income From Continuous Operations19.50B19.15B23.57B45.07B55.68B[{"date":"2020-03-31","value":35.02,"profit":true},{"date":"2021-03-31","value":34.39,"profit":true},{"date":"2022-03-31","value":42.32,"profit":true},{"date":"2023-03-31","value":80.94,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income19.50B17.24B23.57B45.07B55.68B[{"date":"2020-03-31","value":35.02,"profit":true},{"date":"2021-03-31","value":30.96,"profit":true},{"date":"2022-03-31","value":42.32,"profit":true},{"date":"2023-03-31","value":80.93,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
EPS (Diluted)2.761.561.923.33251.10[{"date":"2020-03-31","value":1.1,"profit":true},{"date":"2021-03-31","value":0.62,"profit":true},{"date":"2022-03-31","value":0.76,"profit":true},{"date":"2023-03-31","value":1.33,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RDY
Cash Ratio 0.49
Current Ratio 1.92
Quick Ratio 1.36

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RDY
ROA (LTM) 10.40%
ROE (LTM) 19.27%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RDY
Debt Ratio Lower is generally better. Negative is bad. 0.34
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.66

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RDY
Trailing PE 19.71
Forward PE 19.12
P/S (TTM) 0.04
P/B 3.56
Price/FCF 9
EV/R 3.68
EV/Ebitda 12.28
PEG 4.51

FAQs

What is Dr. Reddy’s Laboratories Ltd ADR share price today?

Dr. Reddy’s Laboratories Ltd ADR (RDY) share price today is $15.49

Can Indians buy Dr. Reddy’s Laboratories Ltd ADR shares?

Yes, Indians can buy shares of Dr. Reddy’s Laboratories Ltd ADR (RDY) on Vested. To buy Dr. Reddy’s Laboratories Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RDY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Dr. Reddy’s Laboratories Ltd ADR be purchased?

Yes, you can purchase fractional shares of Dr. Reddy’s Laboratories Ltd ADR (RDY) via the Vested app. You can start investing in Dr. Reddy’s Laboratories Ltd ADR (RDY) with a minimum investment of $1.

How to invest in Dr. Reddy’s Laboratories Ltd ADR shares from India?

You can invest in shares of Dr. Reddy’s Laboratories Ltd ADR (RDY) via Vested in three simple steps:

  • Click on Sign Up or Invest in RDY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Dr. Reddy’s Laboratories Ltd ADR shares
What is Dr. Reddy’s Laboratories Ltd ADR 52-week high and low stock price?

The 52-week high price of Dr. Reddy’s Laboratories Ltd ADR (RDY) is $16.89. The 52-week low price of Dr. Reddy’s Laboratories Ltd ADR (RDY) is $12.63.

What is Dr. Reddy’s Laboratories Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Dr. Reddy’s Laboratories Ltd ADR (RDY) is 19.7051

What is Dr. Reddy’s Laboratories Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Dr. Reddy’s Laboratories Ltd ADR (RDY) is 3.56

What is Dr. Reddy’s Laboratories Ltd ADR dividend yield?

The dividend yield of Dr. Reddy’s Laboratories Ltd ADR (RDY) is 0.62%

What is the Market Cap of Dr. Reddy’s Laboratories Ltd ADR?

The market capitalization of Dr. Reddy’s Laboratories Ltd ADR (RDY) is $13.11B

What is Dr. Reddy’s Laboratories Ltd ADR’s stock symbol?

The stock symbol (or ticker) of Dr. Reddy’s Laboratories Ltd ADR is RDY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top